Literature DB >> 17922308

Systemic infections in multiple sclerosis and experimental autoimmune encephalomyelitis.

Simone C Tauber1, Roland Nau, Joachim Gerber.   

Abstract

Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS). It has been suggested that viral and bacterial infections contribute to the pathogenesis of MS. This review will give an overview about the influence of viral and bacterial infections on MS and experimental autoimmune encephalomyelitis (EAE). It will focus on bacterial infections and will also emphasise therapeutic consequences such as the impact of antibiotic treatment on the course of EAE. In summary, a growing body of evidence suggests that systemic infections are a risk factor for the initiation of autoimmune processes including the induction of acute events in MS. Experimental and clinical data strongly suggest early treatment of bacterial infections in MS patients to avoid aggravation and relapse.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17922308     DOI: 10.1080/13813450701531227

Source DB:  PubMed          Journal:  Arch Physiol Biochem        ISSN: 1381-3455            Impact factor:   4.076


  6 in total

Review 1.  Disease-Specific Outcomes of Botulinum Toxin Injections for Neurogenic Detrusor Overactivity.

Authors:  Aaron Kaviani; Rose Khavari
Journal:  Urol Clin North Am       Date:  2017-08       Impact factor: 2.241

2.  IDO upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitis.

Authors:  Yaping Yan; Guang-Xian Zhang; Bruno Gran; Francesca Fallarino; Shuo Yu; Hongmei Li; Melissa L Cullimore; Abdolmohamad Rostami; Hui Xu
Journal:  J Immunol       Date:  2010-10-13       Impact factor: 5.422

Review 3.  A review of genome-wide association studies for multiple sclerosis: classical and hypothesis-driven approaches.

Authors:  V V Bashinskaya; O G Kulakova; A N Boyko; A V Favorov; O O Favorova
Journal:  Hum Genet       Date:  2015-09-25       Impact factor: 4.132

Review 4.  Role of pathogens in multiple sclerosis.

Authors:  Jane E Libbey; Matthew F Cusick; Robert S Fujinami
Journal:  Int Rev Immunol       Date:  2013-11-22       Impact factor: 5.311

Review 5.  Toll-like receptors in multiple sclerosis.

Authors:  Michael K Racke; Paul D Drew
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

6.  Systemic Escherichia coli infection does not influence clinical symptoms and neurodegeneration in experimental autoimmune encephalomyelitis.

Authors:  Prateek Kumar; Katharina Friebe; Rieka Schallhorn; Zahra Moinfar; Roland Nau; Mathias Bähr; Sandra Schütze; Katharina Hein
Journal:  BMC Neurosci       Date:  2015-06-19       Impact factor: 3.288

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.